Show simple item record

dc.contributor.authorMoffat, Anthony C.
dc.contributor.authorWatt, Robert A.
dc.contributor.authorAssi, Sulaf
dc.date.accessioned2011-12-14T11:01:05Z
dc.date.available2011-12-14T11:01:05Z
dc.date.issued2010
dc.identifier.citationMoffat , A C , Watt , R A & Assi , S 2010 , ' Identifying counterfeit medicines using near infrared spectroscopy ' , Journal of Near Infrared Spectroscopy , vol. 18 , no. 1 , pp. 115 . https://doi.org/10.1255/jnirs.856
dc.identifier.issn0967-0335
dc.identifier.otherPURE: 491027
dc.identifier.otherPURE UUID: 2edb525c-6316-4a52-bd7a-a3385a3a3cf1
dc.identifier.otherWOS: 000276255800002
dc.identifier.otherScopus: 77951192030
dc.identifier.urihttp://hdl.handle.net/2299/7260
dc.description.abstractCounterfeit medicines are a growing threat to public health across the world and screening methods are needed to allow their rapid identification. A counterfeiter must duplicate both the physical characteristics and the chemical content of a proprietary product to avoid it being detected as a counterfeit product and this is almost impossible to get right. Counterfeit proprietary medicines are, therefore, relatively easy to identify by near infrared (NIR) spectroscopy which can detect physical as well as chemical differences between products by simple spectral comparison. Identifying generic products is more difficult as they use different excipients in the tablet or capsule matrix. Nevertheless, using appropriate models and a large library, NIR spectroscopy can detect counterfeit generic versions. Detecting sub-standard proprietary medicines can be carried out with NIR spectroscopy models and the most widely used is partial least squares regression (PLSR). General rules for generating accurate quantitative models are easy to describe. Quantifying the active pharmaceutical ingredient (API) in generic products can also be carried out using PLSR models with calibration samples generated by manufacturing laboratory samples or by collecting many generic versions of a medicine so as to obtain a good range of the API content in tablets and capsules. Using hand-held instruments or mobile laboratories allows NIR spectrometers to be taken to places where analyses may be made quickly, rather than taking the samples to a laboratory. This has the enormous advantage that the screening of large numbers of samples may be made in pharmacies and wholesalers. Imaging can bring a whole new dimension to NIR spectroscopy to allow the identification of the API and individual excipients as well as measuring the particle sizes of components and giving a measure of the homogeneity of the matrix. The effect of water on potential misidentifications may be obviated by only using blister-packed samples, having large spectral libraries subjected to different humidities or omitting the spectral region where water absorbs.en
dc.format.extent15
dc.language.isoeng
dc.relation.ispartofJournal of Near Infrared Spectroscopy
dc.subjectcounterfeit medicines
dc.subjectsuspect medicines
dc.subjectsub-standard medicines
dc.subjectassay
dc.subjectactive pharmaceutical ingredient
dc.subjectnear infrared spectroscopy
dc.subjectidentification
dc.subjectquantification
dc.subjectDIFFUSE-REFLECTANCE SPECTROSCOPY
dc.subjectUNIVERSAL QUANTITATIVE MODELS
dc.subjectPOWDER PHARMACEUTICAL SAMPLES
dc.subjectINTACT TABLETS
dc.subjectACTIVE-SUBSTANCE
dc.subjectDRUG CONTENT
dc.subjectTRANSMITTANCE SPECTROSCOPY
dc.subjectPARACETAMOL TABLETS
dc.subjectQUALITY-CONTROL
dc.subjectCOATED TABLETS
dc.titleIdentifying counterfeit medicines using near infrared spectroscopyen
dc.contributor.institutionDepartment of Pharmacy
dc.contributor.institutionHealth & Human Sciences Research Institute
dc.description.statusPeer reviewed
rioxxterms.versionofrecordhttps://doi.org/10.1255/jnirs.856
rioxxterms.typeOther
herts.preservation.rarelyaccessedtrue


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record